US Pharma MarketingFoundation Medicine tallied another nod from the FDA for one of its genomic profiling tests that searches for specific biomarkers in tumor tissue samples.
Foundation Medicine tallies FDA nod to pair its blood test with Pfizer’s prostate cancer combo
Foundation Medicine tallies FDA nod to pair its blood test with Pfizer’s prostate cancer combo is a pharma and life sciences industry update from FierceBiotech. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
Source: FierceBiotech